If your email program has trouble displaying this email, view as a webpage. FDA's Budget: Advancing the Goal of Ending the Opioid Crisis As we confronted the COVID-19 pandemic over the past year, many of the existing public health challenges we face as a nation did not suddenly disappear. The opioid crisis in particular has remained an urgent public health priority for the U.S. Food and Drug Administration, particularly as the crisis has continued to expand, devastating families and communities across the nation.  The investments outlined in the FDA's FY 2022 budget request would address current public health needs and allow the agency to design programs intended to tackle complex challenges facing the country, such as those needed in addressing the opioid crisis, by supporting development of new therapies and smarter enforcement.

Stay Connected with U.S. Food and Drug Administration:

SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA